Cheapest Tirzepatide Online in 2026: From $129/mo Compounded to Brand Zepbound

Tirzepatide produced the largest mean weight loss of any GLP-1 medication studied in head-to-head trials, and it is also the most expensive to source. Compounded tirzepatide starts at $129/month all-inclusive at Eden, month to month. Brand-name Zepbound starts at $299/month through Eli Lilly's manufacturer-direct program, with practical caveats. Mounjaro, the same active ingredient sold for diabetes, has no manufacturer self-pay program and runs $1,100–$1,900/month at most telehealth providers (Mochi Health added a lower-cost cash option in 2026). Compounded tirzepatide is not FDA-approved as a finished product, but for uninsured patients, it remains the primary route to a lower monthly price.

The honest framing: compounded tirzepatide is roughly $50–$100/month more than compounded semaglutide across nearly every provider. That premium is structural, not negotiable. If you're optimizing purely for price, semaglutide is cheaper. If you specifically want tirzepatide, the question becomes which compromise you're willing to make.

Eden's $129/mo, then the $169/mo tier: what microdose tirzepatide actually means

The cheapest compounded tirzepatide we track is now Eden at $129/month all-inclusive. Eden dropped its separate membership for compounded medication this fall, and the price is the same at every dose, month to month, with no intro rate (Eden's page also advertises a lifetime price guarantee; that is Eden's claim, so confirm it at checkout). It is a flat full-dose rate, not a microdose program. Eden's $99/month membership still applies to its brand-name medications.

Next comes a three-way tie at $169/month: Enhance.MD's Microdose Tirzepatide program (12-month plan, $99 first month), Found's all-in plan (full-dose compounded tirzepatide included, 12-month plan), and Mochi Health at its starting dose (which climbs to $278/month at the top dose under its per-dose pricing). Shed Microdose Tirz is $199/month on the same commitment.

Both programs use a roughly 1mg/week dose. This is lower than the 5–15mg/week doses used in the SURMOUNT clinical trials that established Zepbound's efficacy (NEJM, 2022). The weight-loss effect at microdose levels is correspondingly smaller. Microdose programs exist for patients prioritizing tolerability, side-effect minimization, lower cost, or maintenance after reaching goal weight. They're not the right fit if you're targeting the full clinical effect seen in trials.

This distinction matters and rarely gets surfaced clearly on provider websites. A microdose program at $169/month is not equivalent to a full-dose program at $280/month with a discount tacked on. They're different products with different therapeutic targets. Compounded tirzepatide at any dose is not FDA-approved as a finished product.

The real cost breakdown

Last verified: October 2026 by RxPickr Editorial Team. Prices reflect our October 2026 pricing refresh and may change; we re-verify pricing monthly. TrimRx, Oak Longevity, bmiMD, MEDVi, and Hers figures are carried forward from earlier checks because their sites blocked our checks this cycle, and PlushCare's Zepbound pricing is carried from May. All-inclusive means medication, supplies, shipping, and follow-up visits are covered in one charge. Separate-fee models charge a monthly membership on top of medication costs.

Compounded tirzepatide

Brand Zepbound

Eden at $129/mo all-inclusive, flat at every dose and month to month, is the cheapest compounded tirzepatide in our data. bmiMD's $179/mo in the table is its 12-month prepaid rate ($249/mo month to month). Enhance.MD Microdose, Found's all-in plan, and Mochi Health at its starting dose tie at $169/mo behind Eden. Enhance.MD's 1mg/wk dose is below the SURMOUNT range, so the weight-loss effect is correspondingly smaller; Found's $169/mo is a full-dose plan on the 12-month prepay ($289/mo month-to-month); Mochi's $169/mo is a starting-dose price that climbs to $278/mo at the top dose under its per-dose pricing. For a flat full-dose rate that doesn't depend on titration, Shed's full-dose compounded tirzepatide was cut to $239/mo on the 12-month plan ($299/mo month-to-month), and TrimRx holds a flat $349/mo at every dose (12-month prepay from $283/mo); TrimRx's previously published $259 tier no longer matches any current plan.

On the brand side, LillyDirect at $299/mo starter is the absolute floor, but the 45-day refill rule is a real trap (more below). PlushCare at $319/mo total ($299 medication plus a $19.99/mo membership) is now the cheapest brand-Zepbound path that includes clinical care, with WeightWatchers Clinic close behind at $373/mo total.

Why compounded tirzepatide costs more than compounded semaglutide

Across providers, compounded tirzepatide runs $50–$100/month more than compounded semaglutide. There's no clinical or regulatory reason for this. It's a supply problem.

The active pharmaceutical ingredient (API) for tirzepatide is harder to source than semaglutide API. Fewer compounding pharmacies stock it, and the bulk substance costs more to acquire. That cost gets passed through to the patient. Expect the gap to persist as long as supply is constrained, regardless of which provider you choose.

If you're optimizing purely for monthly price and don't have a clinical reason to prefer tirzepatide, compounded semaglutide starts at $99/month and can save you $50–$100/month long-term.

Microdose tirzepatide: who it's for and who it isn't

Microdose tirzepatide is a real category with a real use case, but the marketing language tends to blur the boundary between microdose and full-dose. Microdose programs typically use a 1–1.25mg/week injection. SURMOUNT-1, the registrational trial that established Zepbound's efficacy, studied doses of 5mg, 10mg, and 15mg/week.

Microdose makes clinical sense for several patient profiles:

• Patients with a history of significant GI side effects on full-dose GLP-1s
• Patients near goal weight using tirzepatide for maintenance
• Patients prioritizing tolerability and willing to accept a smaller weight-loss effect for a smoother experience
• Patients with cost as the primary constraint

It doesn't make sense if you're targeting the 20%+ body weight reduction seen in SURMOUNT high-dose arms. The dose response for tirzepatide is meaningful: lower dose, smaller effect.

Compounded microdose tirzepatide is not FDA-approved as a finished product, and the specific dose ratios used in microdose programs have not been studied in equivalent clinical trials to the SURMOUNT regimens. Talk to a licensed healthcare provider about whether microdose is appropriate for your situation before signing up.

The LillyDirect 45-day refill trap

LillyDirect is the cheapest verified path to brand Zepbound. At starter doses, you pay $299/month (2.5mg), $399/month (5mg), or $449/month (7.5mg, 10mg, 12.5mg, or 15mg). That pricing is competitive with most compounded options and dramatically cheaper than retail Zepbound, which runs roughly $1,350/month at a typical pharmacy.

There's a catch. Eli Lilly's $449/month self-pay price for the 7.5mg–15mg Zepbound doses is contingent on refilling within a 45-day window. Miss the window, and LillyDirect lists $499/month for 7.5mg and $699/month for 10mg, 12.5mg, or 15mg, per LillyDirect's Zepbound page. Telehealth resellers can charge more out of window: WeightWatchers Clinic lists $599 (7.5mg), $699 (10mg), $849 (12.5mg), and $1,049 (15mg).

The practical takeaway: if you're using LillyDirect at 7.5mg or above, set up refill reminders. Pharmacy fulfillment can take several days, so order a few days before you need the refill, not on the day. If you travel often or your prescription schedule is irregular, the savings may not survive a single missed window.

This is where bundled telehealth providers can earn their membership fee. WeightWatchers Clinic offers brand Zepbound at LillyDirect-equivalent pricing for $373/month total ($299 medication + $74 WW membership), with the clinic handling refill logistics. If you can reliably manage the 45-day window yourself, going direct is cheaper. If you can't, paying $74/month for someone else to track it can be worth it.

Why Mounjaro isn't a cash-pay tirzepatide option

Mounjaro and Zepbound are the same molecule (tirzepatide). The difference is the FDA-approved indication: Mounjaro is approved for type 2 diabetes, Zepbound is approved for obesity and weight management. Eli Lilly priced and marketed them as separate products.

For cash-pay patients, this distinction matters because Lilly offers a manufacturer self-pay program for Zepbound but does not offer one for Mounjaro at weight-loss doses. Most telehealth providers that list Mounjaro list it near retail: $1,100–$1,899/month at Hims, Hers, Oak Longevity, Found, and PlushCare. Mochi Health added a lower-cost cash option in 2026 at $499/month plus its $79/month membership ($578/month total), still roughly double LillyDirect's Zepbound price for the same molecule.

If you want tirzepatide and you're paying cash, Zepbound is the same molecule at a fraction of the price. Mounjaro through telehealth makes financial sense only if your insurance covers Mounjaro (typically requires a type 2 diabetes diagnosis) and your copay is meaningfully lower than your alternatives.

The insurance pathway

For patients with insurance that covers GLP-1s, the cheapest path can be brand Zepbound or Mounjaro with prior authorization. Brand Zepbound copays under coverage typically run $25–$100/month.

The catch is that regular Medicare Part D and most state Medicaid programs exclude Zepbound, though since July 2026 eligible Medicare beneficiaries can get the Zepbound KwikPen for a $50 monthly copay through the temporary Medicare GLP-1 Bridge. Otherwise, coverage is most common through employer-sponsored commercial plans. Mounjaro is more commonly covered but requires a type 2 diabetes diagnosis.

The cheapest insurance-coordinated telehealth paths:

• PlushCare: $19.99/month membership; uses your insurance for the medication. Cheapest membership in the category.
• Mochi Health: $79/month membership; coordinates with insurance for brand-name medications.
• Found: free insurance check and a PLUS pathway at $39/month plus copay if you're approved for brand-name coverage.

If you have coverage and your plan includes Zepbound on its formulary, expect prior authorization paperwork. PlushCare and Found handle the paperwork on your behalf as part of their service.

The compounded medication context

The regulatory situation for compounded tirzepatide has tightened significantly. The FDA declared the tirzepatide shortage resolved on October 2, 2024 (FDA drug shortage database). The agency declared the semaglutide shortage resolved in February 2025. Enforcement discretion that previously allowed 503B outsourcing facilities to compound during the shortages ended in spring 2025.

Eli Lilly has pursued aggressive enforcement, filing lawsuits against telehealth companies and compounding pharmacies marketing compounded tirzepatide. Novo Nordisk has taken similar action on the semaglutide side, filing more than 130 lawsuits across 40 states.

The practical result: 503B outsourcing facilities face significant legal restrictions on compounding tirzepatide. 503A pharmacies (which compound for individual patients on a per-prescription basis) operate under different rules and continue to legally compound tirzepatide in most states. Before ordering, confirm which type of pharmacy your provider uses and whether they have received any FDA or legal notices. A reputable provider will be transparent about this.

For deeper context on the regulatory framework and clinical comparison, see our compounded vs brand-name semaglutide guide, which covers most of the same dynamics that apply to tirzepatide.

Bottom line

For most cash-pay patients seeking the lowest monthly price on tirzepatide, the practical recommendations:

• Cheapest overall: Eden at $129/month all-inclusive for compounded tirzepatide, flat at every dose and month to month with no separate membership.
• Next cheapest, tied at $169/month: Found's all-in plan (full-dose compounded tirzepatide included), Mochi Health at its starting dose (rises to $278/month at the top dose), and Enhance.MD Microdose on a 12-month plan. Honest caveat on the last one: 1mg/week is below the SURMOUNT dose range, so expect a smaller weight-loss effect than full-dose programs.
• Cheapest flat full-dose compounded: Shed at $239/month on a 12-month plan ($299/month month to month), or TrimRx at $349/month flat at every dose (12-month prepay from $283/month) if you want one rate with no dose-based table.
• Cheapest brand Zepbound: LillyDirect direct at $299–$449/month within the 45-day refill window. The cheapest verified path to brand-name medication.
• Cheapest brand Zepbound with clinical care: PlushCare at $319/month total ($299 medication + $19.99 membership), or WeightWatchers Clinic at $373/month total ($299 medication + $74 membership) if you want the WW behavioral program bundled in.
• With insurance: PlushCare at $19.99/month membership plus your copay is the cheapest insurance-coordinated path. Found offers a free insurance check if you're not sure what your plan covers.

A note on Mounjaro: don't choose it for cash-pay weight loss. It's the same molecule as Zepbound at roughly 3x the price at most providers (Mochi Health's newer cash option narrows that to about 1.5x to 2x). Mounjaro through telehealth makes financial sense only with insurance coverage and a type 2 diabetes diagnosis.

Consult a licensed healthcare provider before starting any GLP-1 medication. Your clinical history, current medications, weight-loss goals, and insurance situation all factor into whether tirzepatide is appropriate for you and which formulation makes sense.